We previously showed that MDM2 provides an estrogen-mediated proliferative advantage to breast cancer cells and disrupts acini formation by increasing phosphorylation of Rb and elevating E2F1 protein levels [7]. The gene discussed is MDM2; the disease is breast cancer.